Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2020
Jul. 31, 2019
Jul. 31, 2020
Jul. 31, 2019
Research and Development Expense [Member]        
Non-cash share-based compensation expenses $ 394,842 $ 338,449 $ 1,250,497 $ 2,567,294
General and Administrative Expense [Member]        
Non-cash share-based compensation expenses $ 646,957 $ 492,449 $ 1,922,722 $ 2,335,218